Concord Drugs Limited
BSE: CONCORD.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Seelam Nagi Reddy
- Employees
- 185
- Headquarters
- Hyderabad, India
- IPO year
- 2015
- Market cap
- ₹811.0M
- Website
- http://www.concorddrugs.in
Loading CONCORD…
Loading profile data…Frequently asked questions about CONCORD
What does Concord Drugs Limited (CONCORD.BO) do?
Concord Drugs Ltd. engages in the provision of pharmaceutical formulations. Its products include ready to fill pellets, mup's tissue bio adhesive, injectables, oral solid dosages, oral solid dosages, and liquid orals. The company was founded on April 24, 1995 and is headquartered in Hyderabad, India.
Where does CONCORD.BO trade?
Concord Drugs Limited (CONCORD.BO) trades on the Bombay Stock Exchange.
What sector is CONCORD.BO in?
Concord Drugs Limited (CONCORD.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Concord Drugs Limited?
Seelam Nagi Reddy is the chief executive officer of Concord Drugs Limited (CONCORD.BO).
Where is Concord Drugs Limited headquartered?
Concord Drugs Limited is headquartered in India.
Does CONCORD.BO pay a dividend?
Concord Drugs Limited (CONCORD.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CONCORD.BO go public?
Concord Drugs Limited (CONCORD.BO) completed its initial public offering in 2015.